Delaware judge refuses to block Metsera from ending Pfizer obesity dealnews2025-11-05T21:27:42+00:00November 5th, 2025|Endpoints News|
First Circuit hears arguments over NIH indirect cost cutsnews2025-11-05T20:29:34+00:00November 5th, 2025|Endpoints News|
FDA reviewers were divided over Stealth’s data before Barth drug approvalnews2025-11-05T20:15:07+00:00November 5th, 2025|Endpoints News|
Supernus halts delivery of some Parkinson’s pumps over supply constraintsnews2025-11-05T18:05:08+00:00November 5th, 2025|Endpoints News|
Teva CEO says IRA drug price negotiations met expectationsnews2025-11-05T17:52:56+00:00November 5th, 2025|Endpoints News|
FDA rejects Biohaven’s ataxia drug, shutting down company’s second attempt to win approvalnews2025-11-05T16:39:16+00:00November 5th, 2025|Endpoints News|
Zealand CEO calls on industry to end the ‘weight loss Olympics’news2025-11-05T16:00:29+00:00November 5th, 2025|Endpoints News|
Hepta raises $6.7M to take liquid biopsy into liver diseasenews2025-11-05T16:00:04+00:00November 5th, 2025|Endpoints News|
Soleno’s stock drops despite rise in Prader-Willi drug salesnews2025-11-05T14:40:13+00:00November 5th, 2025|Endpoints News|
Novo Nordisk sales miss underlines its need for Metseranews2025-11-05T10:24:34+00:00November 5th, 2025|Endpoints News|
